1. Home
  2. GRPN vs CRVS Comparison

GRPN vs CRVS Comparison

Compare GRPN & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

HOLD

Current Price

$21.30

Market Cap

1.1B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$11.61

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRPN
CRVS
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
GRPN
CRVS
Price
$21.30
$11.61
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
★ $33.67
$30.17
AVG Volume (30 Days)
★ 1.0M
861.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 48.04
EPS
N/A
★ N/A
Revenue
★ $2,843,877,000.00
N/A
Revenue This Year
$5.55
N/A
Revenue Next Year
$6.63
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.17
$6.39
52 Week High
$29.90
$26.95

Technical Indicators

Market Signals
Indicator
GRPN
CRVS
Relative Strength Index (RSI) 55.68 34.36
Support Level $15.82 $11.13
Resistance Level $22.39 $14.00
Average True Range (ATR) 1.05 0.70
MACD 0.44 -0.13
Stochastic Oscillator 77.38 9.12

Price Performance

Historical Comparison
GRPN
CRVS

About GRPN Groupon Inc.

Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: